Status:

COMPLETED

Sputum Purulence as a Predictor of Cystic Fibrosis Exacerbations: a Prospective Cohort Trial.

Lead Sponsor:

Universitaire Ziekenhuizen KU Leuven

Conditions:

Cystic Fibrosis

Eligibility:

All Genders

18+ years

Brief Summary

To use the sputum colour chart as a predictor for cystic fibrosis exaerbations

Detailed Description

Patients will score their sputum purulence daily using three colour charts. They will also score for respiratory and other symptoms. Primary analysis will focus on the predicting value of sputum puru...

Eligibility Criteria

Inclusion

  • a diagnosis of cystic fibrosis
  • Pseudomonas aeruginosa colonization
  • at least 2 exacerbations in the previous year
  • at least 18 years of age

Exclusion

  • colour blindness

Key Trial Info

Start Date :

December 1 2012

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 1 2014

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT02309229

Start Date

December 1 2012

End Date

January 1 2014

Last Update

December 5 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University hospital Leuven

Leuven, Vlaams-Brabant, Belgium, 3000